UBS Group AG - PRINCIPIA BIOPHARMA INC ownership

PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 9 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PRINCIPIA BIOPHARMA INC
ValueSharesWeighting
Q2 2020$10,000
-94.8%
173
-94.7%
0.00%
Q1 2020$194,000
-74.3%
3,262
-76.4%
0.00%
Q4 2019$756,000
+134.1%
13,799
+20.7%
0.00%
Q3 2019$323,000
+487.3%
11,430
+596.1%
0.00%
Q2 2019$55,000
-5.2%
1,642
-22.3%
0.00%
Q4 2018$58,0002,1130.00%
Other shareholders
PRINCIPIA BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,996,588$56,384,00017.05%
Samsara BioCapital, LLC 383,480$10,829,0007.37%
Sofinnova Investments, Inc. 1,417,258$40,023,0003.62%
Cormorant Asset Management, LP 1,341,896$37,895,0002.31%
Orbimed Advisors 1,605,713$45,345,0000.86%
Redmile Group, LLC 790,006$22,310,0000.75%
PFM Health Sciences, LP 559,553$15,802,0000.47%
RTW INVESTMENTS, LP 270,948$7,652,0000.46%
Baker Brothers Advisors 1,654,029$46,710,0000.32%
UNIVERSITY OF NOTRE DAME DU LAC 24,572$694,0000.21%
View complete list of PRINCIPIA BIOPHARMA INC shareholders